Authors
Latest:
“Bound Upon a Wheel of Fire”: Reflections on TraumaTrauma is the distance between the reach and the grasp for our chosen image.
Latest:
Brain Capital: An Emerging Investment OpportunityBrain Capital: a fresh approach to technologies and investing.
Latest:
What Does the Future Hold for Psychedelic-Assisted Psychotherapy?A growing body of scientific evidence suggests that mind-altering drugs, combined with psychotherapy, are effective treatments for some of the most stubborn psychiatric disorders.
Latest:
The Ethics of ReopeningAt the heart of reopening is protecting both population health and economic health.
Latest:
Market Yourself by Leveraging Digital PlatformsHaving an appropriate presence on social media can help your career.
Latest:
You Say Pain. I Say Addiction. Let’s Call the Whole Thing OffThis CME will inform clinicians with unique and much-needed skill sets in diagnosing substance use disorders and managing co-occurring chronic pain.
Latest:
Chemotherapy-Induced Psychosis in an AdolescentCheck out this case study to learn more about how viral infections might play a role in triggering psychotic disorders.
Latest:
10 Measures and Outcomes to Assess Progress in Eradicating RacismSuggestions to assess outcomes and measure success levels in combatting racism.
Latest:
Antidepressant Response: What’s DNA Got to Do With It?Research using data from the All of Us Research Program seeks to solve the mystery of what makes medications work for some and not others.
Latest:
Telling Humanity’s Brain Story: Insights From Brain CapitalWhich innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Latest:
STAR*D’s Cumulative Remission Rate and Why It Still MattersContesters of STAR*D discuss the impact and relevance of the study's remission rates.
Latest:
Augmentation Strategies for Treatment-Resistant DepressionGiven that two-thirds of patients treated for a major depressive episode will fail to achieve remission of symptoms after 2 or more treatment trials of first-line antidepressants, the probability of remission will further decrease with subsequent medication trials. Treatment strategies for patients with TRD include augmentation, where a medication is added to a current antidepressant versus switching to a different antidepressant.
Latest:
Enhancing Patients' Motivation and Empowerment: A Resident’s PerspectiveEmpowerment has a significant correlation with patients’ overall mental and physical well-being, and has been central to the shift in conceptual framework of mental illness recovery towards a focus on resilience, strength, and control over one’s life.
Latest:
The Impact of Cannabis Use on Medication Adherence: A Particular Focus in PsychosisWhat is the effect of cannabis use on adherence to medications in patients with psychosis?
Latest:
Insights From the 2022 AAPL Annual MeetingThe American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.
Latest:
Recognizing and Addressing Psychiatric Implications of Sleep DisordersWhat sleep disorders are common in older adults and what are the associated risk factors and correlates?
Latest:
Interpret at Your Own Risk: Medical Students as Ad-Hoc Interpreters and Vicarious TraumaWe must educate and provide resources for medical students and institutions.
Latest:
How Cities Can Boost Brain CapitalIn a shock-prone world, city-level thinking is a new approach to optimizing the brain health and brain skills of citizens.
Latest:
Stitching Time: Women and Fiber Art in Psychiatric HistorySewing, weaving, knitting, crochet, and needlework can all be soothing, expressive, and communal. How did women patients in psychiatric history harness the therapeutic and political potential of fiber art? What can we learn about life in psychiatric institutions from their work?
Latest:
Honoring a BrotherJoseph Cofrancesco Jr, MD, MPH, remembers his brother who died of complications from COVID-19, intubated, sedated, and alone.
Latest:
Issues in Regulating DTxWe need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
Latest:
Building the Bridge Between Psyche and Soma: 2021 Sigourney Award WinnerPsychoanalysis and dermatology: this Sigourney Award Winner is bridging the 2 specialties.
Latest:
Interpreting Digital Information in Forensic SettingsHow can digital therapeutics overcome barriers to psychiatric treatment in forensic settings?
Latest:
Psychiatrists Call for End to Cruel and Harmful Immigration PolicyThe Group for the Advancement of Psychiatry (America’s mental health think tank) calls for an end to the use of Title 42 to expel asylum seekers at the southern border. This policy places LGBTIQ asylum seekers in particular danger.
Latest:
REMS for Psychiatric Medications: The Good, the Bad, and the UglySession at the 2023 American Psychiatric Association Annual Meeting shares insights on REMS for psychiatric medications.
